Evidence map›Paper›PMID 36112154›Full record

ArticlePsychopharmacology2022

Novelty-induced locomotor behavior predicts heroin addiction vulnerability in male, but not female, rats.

Brittany N Kuhn, Nazzareno Cannella, Ayteria D Crow, Analyse T Roberts, Veronica Lunerti, Carter Allen, Rusty W Nall, Gary Hardiman, Leah C Solberg Woods, Dongjun Chung and 2 more

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Brittany N KuhnDepartment of Neuroscience, Medical University of South Carolina, 173 Ashley Avenue, BSB 403-MSC 510, Charleston, SC, 29425, USA. kuhnb@musc.edu.
Nazzareno CannellaSchool of Pharmacy, University of Camerino, Camerino, Italy.
Ayteria D CrowDepartment of Neuroscience, Medical University of South Carolina, 173 Ashley Avenue, BSB 403-MSC 510, Charleston, SC, 29425, USA.
Analyse T RobertsDepartment of Neuroscience, Medical University of South Carolina, 173 Ashley Avenue, BSB 403-MSC 510, Charleston, SC, 29425, USA.
Veronica LunertiSchool of Pharmacy, University of Camerino, Camerino, Italy.
Carter AllenDepartment of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.
Rusty W NallDepartment of Psychology, Jacksonville State University, Jacksonville, AL, USA.
Gary HardimanSchool of Biological Sciences, Queen's University Belfast, Belfast, Northern Ireland, UK.
Leah C Solberg WoodsDepartment of Internal Medicine, Wake Forest University, Winston-Salem, NC, USA.
Dongjun ChungDepartment of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.
Roberto CiccocioppoSchool of Pharmacy, University of Camerino, Camerino, Italy.
Peter W KalivasDepartment of Neuroscience, Medical University of South Carolina, 173 Ashley Avenue, BSB 403-MSC 510, Charleston, SC, 29425, USA.
Medical University of South Carolina · USUniversità di Camerino · ITThe Ohio State University · USJacksonville State University · USQueen's University Belfast · GBWake Forest University · US

Funding

DRUG ABUSE TRAINING PROGRAMT32DA007288 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Christopher W Cowan, Rachel Penrod-Martin · 1991 to 2026
$11.8M
COCA: Project 4. Neurocircuit Strategy to Decrease Cocaine Cue ReactivityP50DA046373 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HANLON, COLLEEN A · 2019 to 2023
$9.9M
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent ModelU01DA045300 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Christine Cheng, Dongjun Chung · 2018 to 2026
$6.1M
NIDA NIH HHS P50 DA046373NIDA NIH HHS T32 DA007288NIDA NIH HHS T32DA007288NIDA NIH HHS U01 DA045300NIDA NIH HHS U01DA45300
6 · The paper itself

Abstract

rationaleThe ongoing rise in opioid use disorder (OUD) has made it imperative to better model the individual variation within the human population that contributes to OUD vulnerability. Using animal models that capture such variation can be a useful tool. Individual variation in novelty-induced locomotion is predictive of substance use disorder (SUD) propensity. In this model, rats are characterized as high-responders (HR) or low-responders (LR) using a median split based on distance travelled during a locomotor test, and HR rats are generally found to exhibit a more SUD vulnerable behavioral phenotype.

objectivesThe HR/LR model has commonly been used to assess behaviors in male rats using psychostimulants, with limited knowledge of the predictive efficacy of this model in females or the use of an opioid as the reward. In the current study, we assessed several behaviors across the different phases of drug addiction (heroin taking, refraining, and seeking) in over 500 male and female heterogeneous stock rats run at two geographically separate locations. Rats were characterized as HRs or LRs within each sex for analysis.

resultsOverall, females exhibit a more OUD vulnerable phenotype relative to males. Additionally, the HR/LR model was predictive of OUD-like behaviors in male, but not female rats. Furthermore, phenotypes did not differ in anxiety-related behaviors, reacquisition of heroin-taking, or punished heroin-taking behavior in either sex.

conclusionsThese results emphasize the importance of assessing females in models of individual variation in SUD and highlight limitations in using the HR/LR model to assess OUD propensity.

Indexed as

Exploratory BehaviorHeroin DependenceAnalgesics, OpioidAnimalsFemaleHeroinHumansMaleMotor ActivityRatsAnalgesics, OpioidHeroinAddictionHeroinHigh-responderIndividual variationLow-responderNovelty-induced locomotionRelapseSex differencesVulnerable

Identifiers

PMID36112154
PMCPMC9632364
OpenAlexW4296027676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.